TrialX
Advanced Filters
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
noise

Found 2,825 clinical trials

P Patricia I. Moreno, PhD

Optimizing Quality of Life in Women Living With Metastatic Breast Cancer

The purpose of this study is to develop and tailor an intervention program to improve the quality of life in women living with metastatic breast cancer. In the first phase of this study, we conducted patient focus groups to gather information about the unique challenges of living with MBC and …

18 years and older Female Phase N/A
T Tae-Young Chung, PhD

Clinical Outcome of Extended-depth-of-focus Intraocualr Lens (SAV) Implantation

Clinical outcome of extended-depth-of-focus intraocular lens (SAV) implantation

21 years and older All Phase N/A
M Marielle Engelen

Fiber Metabolism in Chronic Obstructive Pulmonary Disease

The impact of fiber intake on short chain fatty acid (SCFA) metabolism has not been studied in subjects suffering from COPD. The purpose of this study is to compare changes in SCFA metabolism after inulin vs. placebo intake in COPD patients to healthy matched controls. This protocol is an extension …

45 years and older All Phase N/A
P Panagiotis D Bamidis, PhD

Application of LLM Care and Related Affective Computing Systems on People With Parkinson's Disease

The study is an adaptation of the Long Lasting Memories (LLM) (NCT02267499) and the subsequent LLM Care (NCT02313935) projects in patients with Parkinson's Disease (PD). The study aims to examine the viability and any potential benefits of cognitive and physical training, as offered via the ICT-based (non-pharmacological) intervention of LLM …

50-85 years All Phase N/A
B Bo-Hyung Kim

Safety and Pharmacokinetics of DWJ1439 DWJ1464 DWC202003 or DWC202004 in Healthy Volunteers

The purpose of this study is to explore the differences in pharmacokinetics and safety characteristics between Test Drugs(DWJ1439, DWJ1464) and that of Reference Drugs(DWC202003, DWC202004) in healthy adults.

19 years and older All Phase 1
M Manal Hubeish, MD

Effect of Single Dose Antenatal Betamethasone on Neonatal Respiratory Morbidity After Elective Cesarean

Patients undergoing elective C-section will be randomized into two groups. The first group will receive one dose of Betamethasone at least 24 hours before scheduled C-section. The second group will receive placebo.

17-45 years Female Phase N/A
Z Zan Shen, Doctor

A Study to Evaluate the Tolerance Efficacy and Pharmacokinetics of TQB3558 Tablets

This is a study to evaluate the maximum tolerated dose (MTD) , occurrence of all adverse events (AE) and serious adverse events (SAE) , pharmacokinetic parameters and antitumor effect of TQB3558 tablets in Chinese adult patients with advanced solid tumors .The study is divided into phase Ia and phase Ib. …

18-75 years All Phase 1
y yakira izaik, doctor

Physical Activity and Preterm Birth With Cervical Dynamics

this RCT is designed to investigate the influence of physical activity on the risk f preterm birth for women with cervical dynamics.

18-54 years Female Phase N/A
J Jürgen Debus, Prof.

Tissue Retractors for Radiation Therapy of Head and Neck Tumors

The rate of therapy-associated side effects during and after radiotherapy of head and neck tumors is essential. The most effective approach to reducing acute toxicity is to cut out healthy tissue from the radiation field. The distance between the tumor and normal tissue can be individually increased using personalized, 3D …

18-99 years All Phase 2
B BeiGene

Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)

The primary objective of this study is to evaluate and compare major pathological response(MPR) rate and event-free survival (EFS) in participants receiving tislelizumab plus platinum-based doublet chemotherapy as the new additional treatment followed by tislelizumab as adjuvant treatment versus participants receiving placebo plus platinum-based doublet chemotherapy as neoadjuvant treatment followed …

18 years and older All Phase 3

Simplify language using AI